Literature DB >> 9986865

Comparison of the API Candida system with the AUXACOLOR system for identification of common yeast pathogens.

C K Campbell1, K G Davey, A D Holmes, A Szekely, D W Warnock.   

Abstract

Two commercial systems for the identification of yeasts were evaluated by using 159 clinical isolates that had also been identified by conventional biochemical and morphological methods. The API Candida system correctly identified 146 isolates (91.8%), and the AUXACOLOR system correctly identified 145 isolates (91.2%). However, of the 146 isolates identified by the API Candida system, 23 required supplemental biochemical tests or morphological assessment to obtain the correct identification. The AUXACOLOR system gave no identification in 13 cases (8.2%), while the API Candida system gave an unreadable profile in only one case. Incorrect identifications were more common with the API Candida system (12 isolates; 7.5%) than with the AUXACOLOR system (1 isolate; 0.6%).

Entities:  

Mesh:

Year:  1999        PMID: 9986865      PMCID: PMC84570     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  19 in total

1.  Evaluation of the modified API 20C system for identification of clinically important yeasts.

Authors:  W J Buesching; K Kurek; G D Roberts
Journal:  J Clin Microbiol       Date:  1979-05       Impact factor: 5.948

2.  Evaluation of the updated Vitek yeast identification data base.

Authors:  M el-Zaatari; L Pasarell; M R McGinnis; J Buckner; G A Land; I F Salkin
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

3.  The differentiation of Trichophyton mentagrophytes from T. rubrum by a simple urease test.

Authors:  C Philpot
Journal:  Sabouraudia       Date:  1967-02

4.  Comparison of Auxacolor with API 20 C Aux in yeast identification.

Authors:  Maria Willemsen; Johan Breynaert; Sabine Lauwers
Journal:  Clin Microbiol Infect       Date:  1997-06       Impact factor: 8.067

5.  High prevalence of antifungal resistance in Candida spp. from patients with AIDS.

Authors:  D Law; C B Moore; H M Wardle; L A Ganguli; M G Keaney; D W Denning
Journal:  J Antimicrob Chemother       Date:  1994-11       Impact factor: 5.790

6.  Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System.

Authors:  S N Banerjee; T G Emori; D H Culver; R P Gaynes; W R Jarvis; T Horan; J R Edwards; J Tolson; T Henderson; W J Martone
Journal:  Am J Med       Date:  1991-09-16       Impact factor: 4.965

7.  Evaluation of the MicroScan Rapid Yeast Identification panel.

Authors:  G St Germain; D Beauchesne
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

8.  Evaluation of the new API 20C strip for yeast identification against a conventional method.

Authors:  G A Land; B A Harrison; K L Hulme; B H Cooper; J C Byrd
Journal:  J Clin Microbiol       Date:  1979-09       Impact factor: 5.948

Review 9.  Importance of Candida species other than C. albicans as pathogens in oncology patients.

Authors:  J R Wingard
Journal:  Clin Infect Dis       Date:  1995-01       Impact factor: 9.079

10.  Evaluation of the AUXACOLOR system, a new method of clinical yeast identification.

Authors:  K G Davey; P M Chant; C S Downer; C K Campbell; D W Warnock
Journal:  J Clin Pathol       Date:  1995-09       Impact factor: 3.411

View more
  15 in total

1.  Assessment of accuracy of identification of pathogenic yeasts in microbiology laboratories in the United kingdom.

Authors:  Andrew M Borman; Adrien Szekely; Michael D Palmer; Elizabeth M Johnson
Journal:  J Clin Microbiol       Date:  2012-05-30       Impact factor: 5.948

2.  Molecular identification of unusual pathogenic yeast isolates by large ribosomal subunit gene sequencing: 2 years of experience at the United kingdom mycology reference laboratory.

Authors:  Christopher J Linton; Andrew M Borman; Grace Cheung; Ann D Holmes; Adrien Szekely; Michael D Palmer; Paul D Bridge; Colin K Campbell; Elizabeth M Johnson
Journal:  J Clin Microbiol       Date:  2007-01-24       Impact factor: 5.948

3.  Comparative evaluation of three commercial identification systems using common and rare bloodstream yeast isolates.

Authors:  Joseph Meletiadis; Michael Arabatzis; Maria Bompola; Konstantinos Tsiveriotis; Stavroula Hini; Efthymia Petinaki; Aristea Velegraki; Loukia Zerva
Journal:  J Clin Microbiol       Date:  2011-05-04       Impact factor: 5.948

Review 4.  Are the Conventional Commercial Yeast Identification Methods Still Helpful in the Era of New Clinical Microbiology Diagnostics? A Meta-Analysis of Their Accuracy.

Authors:  Brunella Posteraro; Ljupcho Efremov; Emanuele Leoncini; Rosarita Amore; Patrizia Posteraro; Walter Ricciardi; Maurizio Sanguinetti
Journal:  J Clin Microbiol       Date:  2015-05-20       Impact factor: 5.948

5.  Use of amplified fragment length polymorphism analysis to identify medically important Candida spp., including C. dubliniensis.

Authors:  A Borst; B Theelen; E Reinders; T Boekhout; A C Fluit; P H M Savelkoul
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

6.  Evaluation of the VITEK 2 system for rapid identification of yeasts and yeast-like organisms.

Authors:  B Graf; T Adam; E Zill; U B Göbel
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

7.  Rapid molecular identification of pathogenic yeasts by pyrosequencing analysis of 35 nucleotides of internal transcribed spacer 2.

Authors:  Andrew M Borman; Christopher J Linton; Debra Oliver; Michael D Palmer; Adrien Szekely; Elizabeth M Johnson
Journal:  J Clin Microbiol       Date:  2010-08-11       Impact factor: 5.948

8.  Evaluation of the commercial rapid trehalose test (GLABRATA RTT) for the point of isolation identification of Candida glabrata isolates in primary cultures.

Authors:  Mark Fraser; Andrew M Borman; Elizabeth M Johnson
Journal:  Mycopathologia       Date:  2012-01-11       Impact factor: 2.574

Review 9.  Advances in Candida detection platforms for clinical and point-of-care applications.

Authors:  Mohammadali Safavieh; Chad Coarsey; Nwadiuto Esiobu; Adnan Memic; Jatin Mahesh Vyas; Hadi Shafiee; Waseem Asghar
Journal:  Crit Rev Biotechnol       Date:  2016-04-19       Impact factor: 8.429

10.  Candida nivariensis, an emerging pathogenic fungus with multidrug resistance to antifungal agents.

Authors:  Andrew M Borman; Rebecca Petch; Christopher J Linton; Michael D Palmer; Paul D Bridge; Elizabeth M Johnson
Journal:  J Clin Microbiol       Date:  2008-01-16       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.